Green Biotech Europe Deutschland (GBE-D) begrüßt die Initiative der Europäischen Kommission zur Entwicklung eines europäischen Biotech Act II. Der Biotech Act II sollte Pflanzenbiotechnologie und Innovationen in der Pflanzenzüchtung ausdrücklich in seinen Anwendungsbereich einbeziehen.
GBE
Green Biotech Europe Deutschland (GBE-D)
Industry association · Germany
not in the EU Transparency RegisterThis organization files on consultations without a register number, so its record here is built from its filings alone. Register facts (staff, costs, accreditations) are not available for it.
3
positions filed
in the 663 files tracked
2
legislative files
of 663 tracked
2
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 663 consultation files tracked so far (57,738 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Track Green in PolicySpeak: request access →
Work at Green Biotech Europe Deutschland (GBE-D)? so we know who speaks for it.
Their record over time
Green Biotech Europe Deutschland (GBE-D) filed 3 positions between 10 Jun 2026 and 28 Sept 2026, across 2 of the 663 legislative files tracked here, attaching a full position paper 2 times.
What they argued
NGT_2: Green Biotech Europe Deutschland (GBE-D) calls for a predictable process for category 2 from assessment to commercial use. Requirements for further breeding and renewal of approval should take into account existing evidence and experience. Implementation should be uniform across the EU, protecting health and the environment and avoiding unnecessary regulatory burdens.
Filed in German · English published by the European Commission
Green Biotech Europe Deutschland (GBE-D) welcomes the adoption of Regulation (EU) 2026/1388. GBE-D calls for clear rules so that breeders know early what evidence they need and how to breed verified plants. The delegated regulation must lay down binding requirements in this regard. Technical guidelines must remain up-to-date without introducing additional obligations.
Filed in German · English published by the European Commission
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Green Biotech Europe Deutschland (GBE-D) next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.
Showing 5 of 29.
Is this your organization?
Everything on this page comes from Green Biotech Europe Deutschland (GBE-D)’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.